Natalie Gillson
Golisano Children's Hospital of Southwest Florida(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunotherapy and Immune Responses, Neurological Complications and Syndromes, Vaccine Coverage and Hesitancy
Most-Cited Works
- → COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study(2021)830 cited
- → SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)(2021)735 cited
- → Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine(2021)350 cited
- → T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study(2021)177 cited
- → Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study)(2021)119 cited
- → Nerve cross‐sectional area in extremes of age(2012)100 cited
- → Incidence and Demographics of Pediatric Intracranial Hypertension(2017)65 cited
- → T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study(2021)51 cited
- → Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol(2022)48 cited
- → Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine(2021)31 cited